Search

Author/Creator Limsakun, Tharin

1. First‐in‐Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS‐1040, an Inhibitor of the Activated Form of Thrombin‐Activatable Fibrinolysis Inhibitor, in Healthy Subjects. (27th June 2019)

Authors:
Zhou, Jin; Limsakun, Tharin; Yin, Ophelia; Warren, Vance; Zamora, Cynthia; Atiee, George; Kochan, Jarema; Pav, Joseph; Kobayashi, Fumiaki; Vashi, Vijay; Dishy, Victor
Journal:
Journal of clinical pharmacology
Issue:
Volume 59:Number 12(2019)
Page Start:
1669
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS‐1211, a tissue‐nonspecific alkaline phosphatase inhibitor. Issue 4 (12th January 2022)

Authors:
Maruyama, Sonomi; Visser, Hester; Ito, Takashi; Limsakun, Tharin; Zahir, Hamim; Ford, Daniel; Tao, Ben; Zamora, Cynthia A.; Stark, Jeffrey G.; Chou, Hubert S.
Journal:
Clinical and translational science
Issue:
Volume 15:Issue 4(2022)
Page Start:
967
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and Pharmacokinetics of DS‐1040 Drug‐Drug Interactions With Aspirin, Clopidogrel, and Enoxaparin. (27th February 2020)

Authors:
Limsakun, Tharin; Dishy, Victor; Mendell, Jeanne; Pizzagalli, Flavia; Pav, Joseph; Kochan, Jarema; Vandell, Alexander G.; Rambaran, Curtis; Kobayashi, Fumiaki; Orihashi, Yasushi; Warren, Vance; McPhillips, Penny; Zhou, Jin
Journal:
Journal of clinical pharmacology
Issue:
Volume 60:Number 6(2020)
Page Start:
691
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗